Pharmacy
Biotech and pharmaceutical dealmaking has surpassed $106 billion in 2026, driven by the search for innovative therapies in oncology, obesity, rare diseases and precision medicine. For healthcare leaders, the trend highlights how the next generation of treatments is increasingly moving from biotech laboratories into global healthcare markets through strategic acquisitions.
Modern healthcare requires more than clinical expertise. It demands a comprehensive understanding of global medication supply chains and complex financial systems. Pharmacy remains a significant contributor to healthcare costs while serving a vital role in patient safety. As medication expenses increase and regulations become more stringent, pharmacists are increasingly moving beyond dispensing responsibilities into strategic executive leadership positions.





